Welcome to the Institute of Clinical Research

Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.  

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community.  For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.

  

Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

  • Defining and refining standards for our profession
  • Providing a forum for discussion of key issues impacting clinical research
  • Promoting good relations with other healthcare related groups 
  • Providing opportunities for learning and development to enhance professional competence 
  • Enhancing public confidence and understanding of clinical research

 

Current News

Site Enablement: How Sponsors and CROs Can Enhance Their Clinical Trials in a Competitive Landscape

By ICR Secretariat / 19/09/2023 10:36 AM

The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the …

Opening doors

By ICR Secretariat / 19/09/2023 10:34 AM

Following in their footsteps – the young people choosing to follow their parents into the pharmaceutical industry

Pharma has changed a lot in recent y…

J&J to phase out Janssen name in corporate rebrand

By ICR Secretariat / 19/09/2023 10:33 AM

Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be …


NICE gives green light for MSD's Keytruda

By ICR Secretariat / 31/08/2023 03:03 PM

The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study

MSD has revealed that the National Institute for Health and …

Biogen kicks off 1,000 layoffs as part of CEO Chris Viehbacher's 'complete redesign'

By ICR Secretariat / 31/08/2023 03:02 PM

It was only last spring that Biogen started a round of layoffs that eventually shrank the company’s head count by nearly 900 people last year. Now, a …

Men with enlarged prostates offered robotic treatment by fourth University Hospital

By ICR Secretariat / 31/08/2023 03:01 PM

Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue

The Norfolk and Norwich University Hospitals (NNUH) Urology…


Autumn Ethics & GCP Forum - ONLINE - Friday 17th November 2023

By ICR Secretariat / 17/08/2023 03:28 PM

To book via Eventbrite and see the full agenda visit our Website

If you have any questions please email office@icr-global.org 

Green light for one of Europe’s largest life sciences campus

By ICR Secretariat / 17/08/2023 02:55 PM

Reef Group and UBS Asset Management have gained approval to develop one of Europe’s largest life sciences campuses in Stevenage, UK.

Family of Henrietta Lacks sues Ultragenyx over use of HeLa cell line

By ICR Secretariat / 17/08/2023 02:54 PM

The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken withou…


Cannabinoid company expands into oncology

By ICR Secretariat / 02/08/2023 02:34 PM

Oxford Cannabinoid Technologies Holdings (OCTP) – the company developing prescription cannabinoid medicines – is expanding its research and developmen…

Build a More Participant-Focused Trial: Amplify the Patient Voice in Clinical Research Technology Development

By ICR Secretariat / 02/08/2023 02:33 PM

For those of us who use sophisticated digital tools every day, it’s easy to assume that technology always makes life easier. It doesn’t.

TauRx’s deliver Alzheimer’s disease therapy results

By ICR Secretariat / 02/08/2023 02:32 PM

TauRx Pharmaceuticals – a company focused on Alzheimer’s disease (AD) research – has announced results from its pivotal phase 3 LUCIDITY trial.

The st…


Improving the Patient Experience Through Research-Driven Design

By ICR Secretariat / 13/07/2023 03:47 PM

Digital technologies designed to support clinical trial management have evolved greatly over the years, spurred by increasing complexity in study desi…

FDA grants Eisai’s Leqembi full approval, opening door to wider use of Alzheimer’s drug

By ICR Secretariat / 13/07/2023 03:46 PM

On Thursday, the Food and Drug Administration awarded a full approval to the Alzheimer’s disease treatment Leqembi, a decision expected to significant…

How to Harmonize and Interpret the Tsunami of Sensor Data in Clinical Trials

By ICR Secretariat / 13/07/2023 03:45 PM

The surge of wearable sensors is transforming the clinical trial experience for patients, sponsors, and research sites. Sensors can be worn by the pat…


Oh my, it’s AI!

By ICR Secretariat / 12/07/2023 02:36 PM

How can we create trust in AI across the vast pharmaverse?

The proliferation of AI/ChatGPT resources during the initial months of 2023 has raised seve…

'The Top Line': The American Diabetes Association's annual conference, plus this week's headlines

By ICR Secretariat / 12/07/2023 02:33 PM

In this episode of "The Top Line," we talk with Fierce’s Andrea Park and Gabrielle Masson about the latest from the American Diabetes Association's an…

With FDA approval in hand, BioMarin lays out plan to sell $2.9M gene therapy

By ICR Secretariat / 12/07/2023 02:32 PM

BioMarin Pharmaceutical, having secured a long-awaited approval from the Food and Drug Administration, says its focus has now turned to launching its …


Eli Lilly's Mounjaro is primed to overtake Novo Nordisk's popular diabetes and obesity duo: report

By ICR Secretariat / 26/06/2023 01:58 PM

In the battle for superiority in the field of next-gen diabetes and obesity treatments, Novo Nordisk holds the lead as the developer of the metabolism…

FDA delays decision on GSK bone cancer drug acquired in $2B buyout

By ICR Secretariat / 26/06/2023 01:56 PM

  • The Food and Drug Administration has delayed an approval decision for an experimental drug GSK is developing for a type of bone marrow cancer, so it …

MARKETING 'Scrolling Therapy' for Eurofarma by Dentsu Creative nabs Cannes Lions Pharma Grand Prix as traditional players lose out, again

By ICR Secretariat / 26/06/2023 01:55 PM

Last year, the top winners at the prestigious Pharma Lions event at Cannes were not in fact pharma companies, and in 2023 that trend continues as a di…




Events and Courses

Clinical Investigations for Medical Devices - Foundation M2

In this one day course we explore clinical investigations for medical devices.  We will review the latest legi...


Effective Project Management for Clinical Trials (3 Days ) M29

This practical course provides delegates with basic project management techniques that can be applied to clinical trial project management. Learning i...


Statistics for Non-Statisticians M31

Statistics is the art and science of summarising data.  Statistics play an essential role in all stages of clinical research ...


Foundation in Good Clinical Practice (GCP) M22

Clinical trials play a pivotal role in progressing medical knowledge and enhancing patient care. However, as they engage real...


Essentials of Clinical Trial Monitoring M32

This practical course defines the role of the clinical research monitor and explains the interaction with others in key roles as part of the clinical ...


GCP for Experts M27

                            Please email office@icr-g...


Current Jobs